Marta Torres-Torrillas1,2, Elena Damiá1,2, José J Cerón3, José M Carrillo1,2, Pau Peláez1,2, Laura Miguel1,2, Ayla Del Romero1,2, Mónica Rubio1,2, Joaquín J Sopena1,2. 1. Bioregenerative Medicine and Applied Surgery Research Group, Department of Animal Medicine and Surgery, CEU Cardenal Herrera University, CEU Universities, Valencia, Spain. 2. García Cugat Foundation CEU-UCH Chair of Medicine and Regenerative Surgery, CEU Cardenal Herrera University, CEU Universities, Valencia, Spain. 3. Interdisciplinary Laboratory of Clinical Analysis, Interlab-UMU, Regional Campus of International Excellence, Campus Mare Nostrum, University of Murcia, Murcia, Spain.
Abstract
OBJECTIVE: Intraarticular (IA) administration of platelet-rich plasma (PRP) has been proposed as a new strategy to halt osteoarthritis (OA) progression. In patients with severe OA, its potential is limited because it is unable to reach the subchondral bone, so a new strategy is needed, and intraosseous (IO) infiltration has been suggested. The purpose is to assess the impact of IA together with IO infiltration of plasma rich in growth factors (PRGF) in serum hyaluronic acid (HA) and type II collagen cleavage neoepitope (C2C) levels. DESIGN: A total of 32 rabbits were included in the study and randomly divided into 2 groups: control and treatment. A 4-mm chondral defect was created in the medial femoral condyle and IA followed by IO infiltration were performed. Serum C2C and HA levels were measured using enzyme-linked immunosorbent assay (ELISA) tests before infiltration and 28, 56, and 84 days post-infiltration. RESULTS: Significant lower C2C serum levels were obtained in treatment group (IA + IO infiltration of PRGF) at 84 days post-infiltration than in control group (IA infiltration of PRGF + IO infiltration of saline solution), while no significant differences between groups were reported at any other study times. Regarding HA, at 56 days post-infiltration, greater significant levels were seen in the treatment group. However, at 84 days post-infiltration, no significant differences were obtained, although lower levels were reported in the treatment group. CONCLUSIONS: Despite inconclusive, the results suggest that the combination of IA and IO infiltration with PRGF may enhance cartilage and subchondral bone regeneration, but further studies are needed.
OBJECTIVE: Intraarticular (IA) administration of platelet-rich plasma (PRP) has been proposed as a new strategy to halt osteoarthritis (OA) progression. In patients with severe OA, its potential is limited because it is unable to reach the subchondral bone, so a new strategy is needed, and intraosseous (IO) infiltration has been suggested. The purpose is to assess the impact of IA together with IO infiltration of plasma rich in growth factors (PRGF) in serum hyaluronic acid (HA) and type II collagen cleavage neoepitope (C2C) levels. DESIGN: A total of 32 rabbits were included in the study and randomly divided into 2 groups: control and treatment. A 4-mm chondral defect was created in the medial femoral condyle and IA followed by IO infiltration were performed. Serum C2C and HA levels were measured using enzyme-linked immunosorbent assay (ELISA) tests before infiltration and 28, 56, and 84 days post-infiltration. RESULTS: Significant lower C2C serum levels were obtained in treatment group (IA + IO infiltration of PRGF) at 84 days post-infiltration than in control group (IA infiltration of PRGF + IO infiltration of saline solution), while no significant differences between groups were reported at any other study times. Regarding HA, at 56 days post-infiltration, greater significant levels were seen in the treatment group. However, at 84 days post-infiltration, no significant differences were obtained, although lower levels were reported in the treatment group. CONCLUSIONS: Despite inconclusive, the results suggest that the combination of IA and IO infiltration with PRGF may enhance cartilage and subchondral bone regeneration, but further studies are needed.
Authors: Marius E Mayerhoefer; Martin J Breitenseher; Josef Kramer; Nicolas Aigner; Cornelia Norden; Siegfried Hofmann Journal: J Magn Reson Imaging Date: 2005-12 Impact factor: 4.813
Authors: Andrew J Barr; T Mark Campbell; Devan Hopkinson; Sarah R Kingsbury; Mike A Bowes; Philip G Conaghan Journal: Arthritis Res Ther Date: 2015-08-25 Impact factor: 5.156
Authors: Belen Cuervo; Monica Rubio; Joaquin Sopena; Juan Manuel Dominguez; Jose Vilar; Manuel Morales; Ramón Cugat; Jose Maria Carrillo Journal: Int J Mol Sci Date: 2014-07-31 Impact factor: 5.923
Authors: José M Vilar; Mónica Rubio; Giuseppe Spinella; Belén Cuervo; Joaquín Sopena; Ramón Cugat; Montserrat Garcia-Balletbó; Juan M Dominguez; Maria Granados; Asta Tvarijonaviciute; José J Ceron; José M Carrillo Journal: PLoS One Date: 2016-02-17 Impact factor: 3.240
Authors: Laura Miguel-Pastor; Katy Satué; Deborah Chicharro; Marta Torres-Torrillas; Ayla Del Romero; Pau Peláez; José M Carrillo; Belén Cuervo; Joaquín J Sopena; José J Cerón; Mónica Rubio Journal: Front Vet Sci Date: 2022-04-14